The Risks and Dangers of Electronic Cigarettes

Aug.31.2022
The Risks and Dangers of Electronic Cigarettes
Electronic cigarettes are not a safe alternative to traditional smoking and may cause serious lung diseases.

For a long time, using e-cigarettes has been considered a reasonable option, as they are seen as a substitute for traditional cigarettes and a preferred choice for those who wish to quit smoking. Currently, e-cigarettes are facing scrutiny from the scientific community, and experts even suggest that they may be more harmful than traditional cigarettes.


According to a survey conducted by Covitel, a phone survey on risk factors for chronic non-communicable diseases during the pandemic, a significant portion of Brazilian youths use e-cigarettes. 19.7% of individuals aged 18 to 24 are followers of this device, which can be seen as one of the entry points for tobacco consumption.


Are electronic cigarettes riskier than regular cigarettes?


The Brazilian Society of Pathology (SBP) pathologist Alexandre Todorovic Fabro stated in a declaration that electronic cigarettes result in similar diseases as traditional cigarettes, as well as more severe conditions such as lung cell destruction due to combustion caused by the combination of hot steam and toxic substances.


Dr. Fabro compared the damage to lung tissue caused by electronic cigarettes to the toxic smoke inhalation experienced during fires, in order to provide evidence for the harm caused by e-cigarettes. He explained that in cases of this type of damage, "if the person does not die, they will develop pneumonia and leave marks on the lungs, much like internal scars.


In fact, there is a specific name for illnesses caused by the use of e-cigarettes: EVALI. In English, the full name for this term is e-cigarette or vaping product use-associated lung injury/illness, a term that has been in use since October 2019.


Other Complications Caused by Smoking


Aside from the unique diseases that electronic cigarettes may cause, they may also lead to the same issues as traditional cigarettes, such as lung cancer and chronic obstructive pulmonary disease (COPD) – previously known as emphysema. Concerning COPD, Paulo Antônio Morais Faleiros, a pulmonologist from SBP, explains that this is a preventable disease.


These two illnesses are most commonly seen among electronic cigarette users, but research linking this habit to an increased risk of over 10 types of cancer, including bladder cancer, has been conducted on cigarette smokers.


Electronic cigarettes can serve as a gateway to vaporizing.


Individuals who have been smoking for years do not prefer cigarettes with tutti-frutti scents or ones that taste like lemon pie. They prefer the taste and odor of tar. However, for those who have never smoked, these new flavors and aromas are clearly eye-catching," argued pulmonologist Dr. Faleiros.


At this point, it is difficult to observe that the device is actually a substitute for smoking cessation. On the other hand, research shows that electronic cigarettes are popular among young age groups, such as those aged 18 to 24.


Is the e-cigarette being released in Brazil?


It is important to note that Brazil has banned the use of electronic cigarettes. According to the Brazilian Medical Association (AMB) and the Federal Medical Council (CFM), legislation pertaining to electronic cigarettes should remain the same due to potential risks faced by users.


In July of this year, Brazil's National Health Surveillance Agency (Anvisa) declared that the ban on importing, advertising and selling electronic cigarettes and vaping devices would remain in effect following the release of a report on the subject. Despite these measures being taken, illegal sales of e-cigarettes and vaping devices continue to occur throughout the country.


Statement: 1. This article is compiled based on third-party information and is intended for industry exchange and learning. 2. The views expressed in this article do not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity and accuracy of the article contents. The compilation of this article is only for industry exchange and research. 3. Due to the limitations of the compilation level, the compiled article may not express the same views as the original text, so please refer to the original text for accuracy. 4. Regarding any statements or positions related to domestic, Hong Kong, Macao, Taiwan, and foreign affairs, 2FIRSTS maintains full consistency with the Chinese government. 5. Copyright ownership of the compiled information belongs to the original media and authors. If any infringement is found, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

PMI Expands IQOS and VEEV Presence at Frankfurt Airport Through Travel Retail Pop-Ups
PMI Expands IQOS and VEEV Presence at Frankfurt Airport Through Travel Retail Pop-Ups
According to The Moodie Davitt Report, PMI Global Travel Retail and Frankfurt Airport Retail have launched new IQOS and VEEV retail spaces at Frankfurt Airport. The installations, located inside and outside duty-free areas, showcase IQOS heated tobacco products and VEEV e-vapor products through product education, consumer interaction and brand experiences. Frankfurt Airport Retail, operated by Fraport Group and Gebr. Heinemann, manages key retail activities at Frankfurt Airport. The initiative follows PMI’s broader strategy of expanding smoke-free products through global travel retail channels. PMI has previously introduced VEEV products across multiple European airports while continuing to expand IQOS and VEEV availability in international markets.
Jul.17
China’s Jinhua Tobacco Launches CNY 2.7 Million Procurement for E-Cigarette Violation Lead Monitoring Services
China’s Jinhua Tobacco Launches CNY 2.7 Million Procurement for E-Cigarette Violation Lead Monitoring Services
Jinhua Tobacco, a municipal tobacco company in China’s Zhejiang province, has launched a public tender for e-cigarette-related violation lead monitoring and consulting services. The project is valued at CNY 2.7 million and covers data resource integration and analytical consulting services for 36 months from contract signing. The procurement reflects the use of external data and analysis services to support local tobacco companies’ market oversight activities related to e-cigarettes.
Aug.07
JTI Research Finds 31% of UK Respondents Offered Illicit Tobacco, While 63% of Ennis Packs Lack Duty Marks
JTI Research Finds 31% of UK Respondents Offered Illicit Tobacco, While 63% of Ennis Packs Lack Duty Marks
Multiple JTI-backed studies in the UK and Ireland indicate that illicit tobacco remains visible across consumer interactions and local markets. In the UK, JTI research found that 31% of respondents said they had been offered illicit tobacco products. In Ireland’s Ennis area, a JTI-commissioned empty pack survey found that 63% of sampled cigarette packs did not carry Irish duty-paid markings. The findings come from industry research rather than official government estimates of illicit tobacco market size, but highlight continued concerns among regulators, legitimate retailers and tobacco companies over illicit trade.
Aug.19
Nevada Considers Nearly Doubling Tobacco Taxes, With $65 Million in New Revenue Expected From Expanded Nicotine Levies
Nevada Considers Nearly Doubling Tobacco Taxes, With $65 Million in New Revenue Expected From Expanded Nicotine Levies
Health groups in Nevada are urging lawmakers to nearly double the state cigarette tax and extend similar tax changes to other nicotine products, including e-cigarettes and nicotine pouches.
Jul.17
Product | PMI Japan Expands ZYN by IQOS Strength Portfolio With Strong Series, Increasing Lineup to 12 Products
Product | PMI Japan Expands ZYN by IQOS Strength Portfolio With Strong Series, Increasing Lineup to 12 Products
Philip Morris Japan (PMJ) has expanded the ZYN by IQOS oral tobacco pouch portfolio in Japan with four new ZYN Strong products, adding a third intensity level alongside the existing Low and Medium ranges. The Strong series first entered selected duty-free channels in Japan on July 1, 2026, before expanding to IQOS stores, the ZYN Online Store and selected tobacco retailers from August 18. The expansion increases the Japanese ZYN by IQOS lineup from eight to 12 products.
Aug.20
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA has published a Special Communication offering systematic recommendations for U.S.-based clinicians on the use of nicotine e-cigarettes in adult smoking cessation. Developed by the Harm Reduction Workgroup of the Society for Research on Nicotine and Tobacco’s Treatment Research Network, the paper recommends including e-cigarettes alongside FDA-approved cessation medications in risk-benefit discussions. It cites high-certainty evidence that nicotine e-cigarettes achieve higher quit rates than nicotine replacement therapy and evidence suggesting efficacy comparable to highly effective medications such as varenicline and cytisine. For adults who choose vaping to quit, the authors recommend FDA-authorized products, sufficient nicotine delivery and a rapid, complete transition away from cigarettes rather than prolonged dual use.
Aug.13